Erlotinib

Erlotinib

SCHEMBL28576829

C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1.[Ag]

nearest known ligand 0.98

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

EGFR

The experimentally established mechanism targets of Erlotinib. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR known ✓ P00533 15/20 0.98
ERBB2 P04626 4/20 0.98
GAK O14976 3/20 0.98
ILK Q13418 3/20 0.98
FLT1 P17948 2/20 0.98
KDR P35968 2/20 0.98
PLK4 O00444 1/20 0.98
CIT O14578 1/20 0.98
AURKA O14965 1/20 0.98
EPHB6 O15197 1/20 0.98
SLC22A1 O15245 1/20 0.98
DAPK3 O43293 1/20 0.98
RIPK2 O43353 1/20 0.98
BUB1 O43683 1/20 0.98
KDM1A O60341 1/20 0.98
JAK2 O60674 1/20 0.98
RPS6KA4 O75676 1/20 0.98
STK17B O94768 1/20 0.98
STK10 O94804 1/20 0.98
SLCO2B1 O94956 1/20 0.98

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Erlotinib SCHEMBL3667407 0.99 EGFR (1.00) EGFRERBB2GAKILKFLT1
Erlotinib SCHEMBL8413 0.99 EGFR (1.00) EGFRERBB2GAKILKFLT1
Erlotinib SCHEMBL29351329 0.99 EGFR (1.00) EGFRERBB2GAKILKFLT1
Erlotinib SCHEMBL30362833 0.99 EGFR (1.00) EGFRERBB2GAKILKFLT1
Erlotinib SCHEMBL16767632 0.98 EGFR (1.00) EGFRERBB2GAKILKFLT1
Erlotinib SCHEMBL1959332 0.98 EGFR (0.98) EGFRERBB2GAKILKFLT1
Erlotinib SCHEMBL29460839 0.98 EGFR (1.00) EGFRERBB2GAKILKFLT1
Erlotinib SCHEMBL417841 0.98 EGFR (0.98) EGFRERBB2GAKILKFLT1
Erlotinib SCHEMBL21176918 0.98 EGFR (1.00) EGFRERBB2GAKILKFLT1
Erlotinib SCHEMBL18563 0.98 EGFR (1.00) EGFRERBB2GAKILKFLT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114478402-B Light-induced synthesized near-infrared luminescent erlotinib silver nanocluster and preparation method thereof 福州大学 2023-09-05 CN claimed
CN-114478402-A Light-induced synthesis near-infrared light-emitting erlotinib silver nanocluster and preparation method thereof 福州大学 2022-05-13 CN claimed
CN-108865147-B Erlotinib-protected platinum-silver nano-cluster and preparation method thereof 福州大学 2021-05-18 CN claimed
CN-114478402-B Light-induced synthesized near-infrared luminescent erlotinib silver nanocluster and preparation method thereof 福州大学 2023-09-05 CN disclosed
CN-114478402-B Light-induced synthesized near-infrared luminescent erlotinib silver nanocluster and preparation method thereof 福州大学 2023-09-05 CN disclosed
CN-114478402-B Light-induced synthesized near-infrared luminescent erlotinib silver nanocluster and preparation method thereof 福州大学 2023-09-05 CN disclosed
CN-114478402-A Light-induced synthesis near-infrared light-emitting erlotinib silver nanocluster and preparation method thereof 福州大学 2022-05-13 CN disclosed
CN-114478402-A Light-induced synthesis near-infrared light-emitting erlotinib silver nanocluster and preparation method thereof 福州大学 2022-05-13 CN disclosed
CN-114478402-A Light-induced synthesis near-infrared light-emitting erlotinib silver nanocluster and preparation method thereof 福州大学 2022-05-13 CN disclosed
CN-108865147-B Erlotinib-protected platinum-silver nano-cluster and preparation method thereof 福州大学 2021-05-18 CN disclosed